Upcoming Special Issue: Prevailing and imminent approaches in tumor, inflammation and fibrosis specific drug delivery
Experimental papers and reviews welcome
Recent progress in novel drug delivery technology has triggered the development of site specific drug carriers and gained wide acknowledgment in contemporary therapeutics. This emerging paradigm in targeted drug delivery provides a promising approach to eradicating various incurable diseases like tumors, inflammation and fibrosis.
The present issue provides a comprehensive overview of the potential of various delivery systems, viz., lipoplexes, liposomes, polyplexes, nanoparticles and so forth to selectively relocate therapeutic drug moiety into specific cell type via the receptor mediated endocytosis.
Nano Reviews is indexed in PubMed.
- Atul Pathak, Dr. Reddy’s Laboratories Ltd, India.
- Yoshiyuki Morishita, Jichi Medical University, Japan
How to submit:
Please go to the journal website at http://www.nano-reviews.net, read the author instructions carefully, click the “Submit a manuscript” button in the upper right-hand corner and follow the instructions. Select “Special Issue: Prevailing and imminent approaches respectively.”
All submissions are due by November 30, 2016.
Regular publication fee applies.